• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review.

作者信息

Parisi Giuseppe Fabio, Portale Anna, Papale Maria, Tardino Lucia, Rotolo Novella, Licari Amelia, Leonardi Salvatore

机构信息

Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

出版信息

J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1636-1638. doi: 10.1016/j.jaip.2019.01.056. Epub 2019 Feb 15.

DOI:10.1016/j.jaip.2019.01.056
PMID:30772479
Abstract
摘要

相似文献

1
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review.奥马珠单抗成功治疗囊性纤维化患者的变应性支气管肺曲霉病：病例报告及文献综述
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1636-1638. doi: 10.1016/j.jaip.2019.01.056. Epub 2019 Feb 15.
2
Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.针对囊性纤维化患者过敏性支气管肺曲霉病的奥马珠单抗病例系列。
Pediatr Pulmonol. 2017 Feb;52(2):190-197. doi: 10.1002/ppul.23612. Epub 2016 Oct 7.
3
Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.奥马珠单抗治疗囊性纤维化合并变应性支气管肺曲霉病的年轻患者。
Respir Med. 2017 Dec;133:12-15. doi: 10.1016/j.rmed.2017.11.007. Epub 2017 Nov 10.
4
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.抗IgE疗法用于治疗囊性纤维化患者的过敏性支气管肺曲霉病。
Cochrane Database Syst Rev. 2015 Nov 4(11):CD010288. doi: 10.1002/14651858.CD010288.pub3.
5
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.针对囊性纤维化患者的过敏性支气管肺曲霉病的抗IgE治疗。
Cochrane Database Syst Rev. 2018 Mar 18;3(3):CD010288. doi: 10.1002/14651858.CD010288.pub4.
6
Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.奥马珠单抗和美泊利单抗联合治疗难治性变应性支气管肺曲霉病
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1137-1139. doi: 10.1016/j.jaip.2017.01.013. Epub 2017 Mar 6.
7
Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.奥马珠单抗治疗囊性纤维化儿童的变应性支气管肺曲霉病：已发表证据的综合分析
Pediatr Pulmonol. 2014 May;49(5):503-7. doi: 10.1002/ppul.22937. Epub 2013 Oct 25.
8
Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations:  II. Therapies for allergic bronchopulmonary aspergillosis.囊性纤维化肺部感染加重的抗菌药物优化治疗：II. 变应性支气管肺曲霉病的治疗。
Pediatr Pulmonol. 2020 Dec;55(12):3541-3572. doi: 10.1002/ppul.25080. Epub 2020 Sep 29.
9
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.抗IgE疗法用于治疗囊性纤维化患者的过敏性支气管肺曲霉病。
Cochrane Database Syst Rev. 2013 Sep 17(9):CD010288. doi: 10.1002/14651858.CD010288.pub2.
10
Omalizumab for treatment of ABPA exacerbations in CF patients.奥马珠单抗用于治疗囊性纤维化患者的ABPA加重期。
Pediatr Pulmonol. 2009 May;44(5):516. doi: 10.1002/ppul.21002.

引用本文的文献

1
Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis.变应性支气管肺曲霉病患者使用生物制剂的疗效：系统评价和荟萃分析。
Lung. 2024 Aug;202(4):367-383. doi: 10.1007/s00408-024-00717-y. Epub 2024 Jun 19.
2
Clinical Manifestations of Human Exposure to Fungi.人类接触真菌的临床表现。
J Fungi (Basel). 2023 Mar 21;9(3):381. doi: 10.3390/jof9030381.
3
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review.
生物制剂治疗囊性纤维化患者变应性支气管肺曲霉病的系统评价。
Eur Respir Rev. 2022 Jul 27;31(165). doi: 10.1183/16000617.0011-2022. Print 2022 Sep 30.
4
An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics.人源化单克隆抗体在儿科领域的超说明书使用概述。
Medicina (Kaunas). 2022 Apr 29;58(5):625. doi: 10.3390/medicina58050625.
5
Allergic Diseases Caused by Species in Patients with Cystic Fibrosis.囊性纤维化患者中由特定物种引起的过敏性疾病。
Antibiotics (Basel). 2021 Mar 28;10(4):357. doi: 10.3390/antibiotics10040357.
6
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review.奥马珠单抗治疗常规治疗抵抗性春季角结膜炎的临床疗效与安全性：我们的经验及文献综述
Immun Inflamm Dis. 2021 Mar;9(1):3-7. doi: 10.1002/iid3.384. Epub 2021 Jan 12.
7
Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation.囊性纤维化肺病及肺移植后呼吸道真菌感染的最新进展
J Fungi (Basel). 2020 Dec 21;6(4):381. doi: 10.3390/jof6040381.
8
Novel therapeutic targets for allergic airway disease in children.儿童过敏性气道疾病的新型治疗靶点
Drugs Context. 2019 Jul 9;8:212590. doi: 10.7573/dic.212590. eCollection 2019.